Centre Hospitalier Eure-Seine
Évreux, 27000, France
Location status: Recruiting
Location contact
AIDENE Dihia
CONTACT
BEN BEKKOU Lydia
CONTACT
NCT Number: NCT05684770
The goal of this clinical trial is to learn about the feasibility and impact of remote care in patients diagnosed with thromboembolic disease of low risk. The main questions it aims to answer are:
* the evaluation of feasibility of organisation between different healthcare professionals (hospital physicians, primary care physician) at 6 months and 1 year * the evaluation of complication rate, hospitalisation related to thromboembolic disease rate, compliance to treatment rate at 6 months and 1 year Participants will receive indication of treatment according to national recommendations. Additionnally, they will receive for the length of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Évreux, 27000, France
Location status: Recruiting
AIDENE Dihia
CONTACT
BEN BEKKOU Lydia
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive for the whole period of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.
Time frame: 6 months
Three scales were created for this study :
Time frame: 1 year
Three scales were created for this study :
Time frame: 6 months and 1 year
Time frame: 1 year
Time frame: 6 months and 1 year
This will be evaluated by the communication between the physician and the patient during consultation
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Eure-Seine
Other
Evaluation of Feasibility and Impact of Remote Care in Patients With Thromboembolic Disease of Low Risk
Acronym: TEVEDOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07302620
Cardiovascular Diseases, Embolism and Thrombosis
Strasbourg, France
View Trial DetailsNCT04861506
Cardiovascular Diseases, Efficacy, Self
Hangzhou, Zhejiang, China
View Trial DetailsNCT05711173
Cardiovascular Diseases, Clonal Hematopoiesis of Indeterminate Potential
Bordeaux, France
View Trial DetailsNCT06201598
Aneurysm, Brain Diseases
A Coruña, Spain
View Trial Details